http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4007193-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
filingDate | 1975-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1977-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cab67852cd03067745560faeb1a20f71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fff6f479e77ab17e982962c41ffa3d29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_713e276a5d47edd334f9175f71af0c3d |
publicationDate | 1977-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4007193-A |
titleOfInvention | Substituted 3-(2-pyridinyl)-4(1H)-quinolinone N-oxides |
abstract | Substituted 3-(2-pyridinyl)-4-(1H)-quinolinone N-oxides having the formula I: ##STR1## wherein R 1 is hydrogen, halogen, lower alkyl, hydroxy or alkoxy; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or --CH 2 OH; the dotted line indicates the possible presence of a double bond at the 2,3-position of the quinoline ring; the pharmaceutically acceptable acid addition salts thereof; and a process for the preparation thereof, are described. The compounds of the invention are useful for the treatment of hyperacidity and for the prevention of allergic and asthmatic reactions. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4076716-A |
priorityDate | 1975-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.